FDA-Inspected Site

Ajanta Pharma USA Inc

3 FDA inspections are on record for Ajanta Pharma USA Inc in Bridgewater, United States.

483· Form 483 issued

Bridgewater, United States · Last updated August 15, 2026

Overview

  • 3 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-07-22.

At a glance

Inspections

3

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
15 Jul 2025 – 22 Jul 2025Human Drugs483View 483 →
28 Mar 2018 – 4 Apr 2018Human DrugsClean
11 Mar 2016 – 17 Mar 2016Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

22 Jul 2025
21 CFR 314.80(b)

Failure to develop written procedures

Cited by Jay B Shah

17 Mar 2016
21 CFR 314.80(c)(2)

Interval

Cited by Michael Serrano

17 Mar 2016
21 CFR 314.80(c)(2)

Late submission of quarterly safety reports

Cited by Michael Serrano

17 Mar 2016
21 CFR 314.81(b)(2)

Timely submission

Cited by Michael Serrano

17 Mar 2016
21 CFR 314.80(c)(2)

Late submission of quarterly safety repo

Cited by Michael Serrano

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 314.80(c)(2)Cited across public-safe Form 483 observations3x
21 CFR 314.80(b)Cited across public-safe Form 483 observations1x
21 CFR 314.81(b)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Ajanta Pharma USA Inc's 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat